Waypoint Bio
Pre-clinicalWaypoint Bio is a biotechnology company pioneering the next generation of cell therapies for solid tumors.
Founded
2021
Focus
Cell TherapyOncology
About
Waypoint Bio is a biotechnology company pioneering the next generation of cell therapies for solid tumors.
Funding History
2Total raised: $30M
Series A$25MAndreessen HorowitzOct 15, 2023
Seed$5MAndreessen HorowitzMar 15, 2022
Company Info
TypePrivate
Founded2021
LocationNew York, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile